Galderma Group AG (SWX:GALD)
160.80
-5.05 (-3.04%)
Oct 1, 2026, 5:30 PM CET
Galderma Group AG Employees
Galderma Group AG had 7,676 employees as of December 31, 2025. The number of employees increased by 1,131 or 17.28% compared to the previous year.
Employees
7,676
Change
1,131
Growth
17.28%
Revenue / Employee
623.47K CHF
Profits / Employee
90.84K CHF
Market Cap
37.50B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7,676 | 1,131 | 17.28% |
| Dec 31, 2023 | 6,545 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,267 |
| Alcon | 25,000 |
| Lonza Group AG | 20,141 |
| Sandoz Group AG | 20,000 |
| Sonova Holding AG | 18,590 |
| Straumann Holding AG | 11,582 |
| Galenica AG | 6,623 |
Galderma Group AG News
- 1 day ago - EADV 2026: Galderma's New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis - Business Wire
- 8 days ago - EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences - Business Wire
- 10 days ago - Galderma Begins Trading in the Swiss Market Index, Joining Switzerland’s Leading Blue Chip Companies - Financial Post
- 13 days ago - Galderma mindful of focus while eyeing product range expansion, CEO tells FuW - Reuters
- 15 days ago - Galderma Reports Positive Topline Results For Restylane Volyme In Temple Hollowing Study - Nasdaq
- 15 days ago - Galderma's Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing - Business Wire
- 26 days ago - Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze. - Market Watch
- 7 weeks ago - Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping - Business Wire